FDA Investigator Kara L Roden
Kara L Roden has conducted inspections on 53 sites in 1 countries as of 05 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
53
Last Inspection Date:
05 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Kara L Roden:
Adree N Anderson,
Alan M Barker,
Alex M Viehmann,
Amir A Abdalla,
Ana Paulap Sandee,
Anna L Tucker,
Anthony R Bucks,
April K Hill,
Ashlee M Ward,
Ashley A Mutawakkil,
Audrey N Vigil,
Barbara I Rogolsky,
Blondell W Johnson,
Bonnie E Pierson,
Brenda C Hamilton,
Brian R Cronenwett,
Bruce E Taylor,
Carl A Huffman, III,
Carl J Montgomery,
Carmen Y Fisher,
Catherine R Olguin,
Catherine Whiteside, PhD,
Chad W Rice,
Cody J Alley,
Cynthia M Goudeau,
Dana D Carter, SR DDS,
Danial S Hutchison,
Darrah,
David A Foran,
David E Lowe,
David F Graham,
Dawn C Olenjack,
Dewayne E Whitlock,
Diana M Guidry,
Dina K West,
Dwight D Ferguson,
Edward E Lockwood (EEL),
Elmina E Mboh,
Eric C Fox,
Eric C Nielsen,
Eric M Mueller, PharmD,
Eric M Padgett,
Erika V Butler,
Erin C Dugan,
Farhana Khan,
Frank Wackes,
George Ivan Wey,
Georgia A Layloff,
Gloria J Champagne,
Gwyn G Dickinson,
Heath W Cartwright,
Ingrid Y Johnson,
Jacob G Lutz,
James D Planchon,
James I Giefer,
James J Houlihan,
James K Rice,
Janet B Abt,
Janete A Oliveira,
Jeffery A Hangartner,
Jeffrey B Moody,
Jennifer Cahill,
Jessica L Peterson,
Jimmie L Weigand,
Jin Young Park, PhD,
John A Iwen,
John C Mcmichael,
John J Welsh, PhD,
Johnson,
Jonathan R Campos,
Joohi Castelvetere,
Joseph R Lambert,
Joseph R Strelnik,
Juandria V Williams,
Julie N Vosilus,
Justin A Boyd,
Kamara Mo,
Karen C Daugherty,
Karen M Cruz Arenas,
Karen M Montgomery (KMM),
Karthik B Iyer,
Katherine M Taylor,
Kathleen B Swat,
Kathleen M Bradley,
Kellia N Hicks,
Kelly D Sheppard,
Kenneth D Bland,
Kevin A Beavers,
Kimberlee A Ewing,
Kristi B Panzer,
Kristi M Hampton Thurston,
Laura S Huffman,
LCDR Audra J Lenhart,
LCDR Matthew J Morrison,
Linhart,
Lionell L Thomas,
Lisa L Flores,
Lisa L Gilliam,
Lisa L Tung,
Lisa W Flores,
Lori A Gioia,
Louis S Chen,
Lyndsey G Smith,
Margaret A Smithers,
Mark G Peterson,
Mary K Concannon,
Matthew A Walburger,
Matthew H Hunt,
Matthew Ondeck,
Matthew P Barnard,
Matthew R Sleeter,
Melinda L Rice,
Melva J Palmer,
Michael A Feingold,
Michael S Smoker,
Michele L Obert,
Michele Perry Williams,
Michelle C Webb,
Minerva Rogers,
Monica Cburgos Garcia,
Monica M Mcclure,
Nadine Nanko Johnson,
Nancy G Schmidt,
Naseem S Jouhari,
Pamela L Velez Vega,
Patricia L Payne,
Patrick L Wisor,
Peter M Boyt,
Phillip M Pontikos,
Ponzoj,
Randy D Baxter,
Rashonda N Rucker,
Regina T Brown,
Rendall E Barfoot,
Rick L Friedman,
Rita K Kabaso,
Robert J Ham,
Robert R Wilson,
Robin K Reel,
Rohit B Kolhatkar,
Samuel K Gibbons, Jr,
Sandra A Boyd,
Sandra A Hughes,
Sarah E Morris,
Shafiq S Ahadi,
Shanna R Haden,
Sharon K Thoma, PharmD,
Sheri L Stephenson,
Sherry G Bous,
Shirley J Berryman,
Sidney B Priesmeyer,
Steven D Kehoe,
Steven P Allen,
Stroman,
Susanna E Ford,
Tara L Breckenridge,
Tara L Greene,
Tara L King,
Ted L Anderson,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Torrey M Ward,
Trevor A Parker,
Tristian E Strait,
Vanessa J Stefka,
Verlinda A Narcisse,
Veronica Fuentes, MS,
Veronica L Call,
Victoria A Wagoner,
Vioela J Caze,
Walsworth,
Warren J Lopicka,
Wayne D Mcgrath,
Wayne W Grundstrom,
Weston K Szymanski,
William C Corley,
William F Lagud, Jr,
Zachary A Bogorad,
Zedong Dong
Kara L Roden's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2000 | FDA 483 | Health n Home - Form 483, 2000-11-03 |
June, 2008 | FDA 483 | Meridian Medical Technologies, LLC - Form 483, 2008-06-13 |
January, 2019 | FDA 483 | SpecGx LLC - Form 483, 2019-01-25 |
February, 2009 | FDA 483 | Kv Pharmaceutical Inc - Form 483, 2009-02-02 |
November, 2000 | EIR | Health n Home - EIR, 2000-11-03 |
April, 2015 | EIR | ADM Animal Nutrition - EIR, 2015-04-02 |
June, 2009 | FDA 483 | Central Admixture Pharmacy Services Inc - Form 483, 2009-06-30 |
January, 2019 | FDA 483 Response | SpecGx LLC - Form 483R, 2019-02-15 |
February, 2008 | FDA 483 | Sparhawk Laboratories, Inc. - Form 483, 2008-02-15 |
January, 2019 | EIR | SpecGx LLC - EIR, 2019-01-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more